Cost-effectiveness of interferon-alpha for chronic myeloid leukemia.
Goldman
J M
JM
D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D016898:Interferon-alpha / Q000191:economics* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000191:economics; D006113:United Kingdom
D016898:Interferon-alpha